Peptide Stack Interaction Checklist: Document Concurrent Compounds for Your Provider
A stack is any combination of peptides, hormones, GLP-1 medicines, diabetes drugs, psychiatric meds, and supplements you take close enough in time that interactions matter. Online communities celebrate stacks; clinicians see confounded risk. The fix is not secrecy—it is documentation.
Use this checklist before appointments, telehealth check-ins, or emergency visits. PeptIQ stores the answers so you are not reconstructing six months from memory. Educational only; your prescriber decides what is safe to continue.
Why Stacks Break Signal
When outcomes change—weight plateaus, nausea spikes, sleep crashes—you need to know what changed. Stacks make attribution hard:
- Was it the new GH secretagogue or the GLP-1 titration?
- Was it thyroid medication adjustment or mitochondrial peptide experimentation?
- Was it a contaminated vial or a true drug interaction?
Clean concurrent-compound lists restore signal. Pair them with half-life logging concepts and injection site journals.
Section 1: Prescription Medicines
List every prescription with dose, route, frequency, start date, and prescriber:
- GLP-1 receptor agonists (semaglutide, tirzepatide, etc.—brand names matter)
- Insulin and other glucose-lowering drugs
- Thyroid hormones
- Blood pressure medicines
- SSRIs/SNRIs and mood stabilizers
- Anticoagulants and antiplatelets
- Immunosuppressants
- Hormone replacement therapies
Note planned changes in the next 30 days (titration, switch, stop).
Section 2: Compounded and Clinic-Dispensed Peptides
Document:
- Compound name on label (not forum nickname)
- Pharmacy or clinic name and contact
- Beyond-use date if provided
- Lot or batch identifiers
- Route (SC, IM, intranasal, etc.)
If you also buy research-labeled vials, say so honestly. Clinicians need channel facts, not euphemisms.
Section 3: Over-the-Counter and Supplement Stack
Include:
- Vitamins and minerals (especially chromium, berberine)
- Fiber supplements affecting GI symptoms
- Stimulant fat burners
- Herbal GLP-1 “mimetic” products
- Protein powders with added bioactives
- Sleep aids (melatonin, antihistamines)
GI stacks overlap with GLP-1 side effects and can confuse nausea logs.
Section 4: Timing and Overlap Map
For each item, note:
- Clock time of administration
- Fasting vs fed context if relevant
- Same-day injections in different anatomical sites
- Washout periods when stopping (dates, not guesses)
Section 5: Quality and Source Notes
Attach:
Quality problems mimic interactions (degraded peptide → unexpected symptoms).
Section 6: Goals and Stop Rules
Write one sentence each:
- Why each compound was added (clinical indication vs experimentation)
- What success looks like (lab target, symptom relief, trial endpoint)
- What would make you stop (side-effect threshold, clinician order, supply issue)
GLP-1–Specific Interaction Themes (Ask Your Clinician)
Labeled GLP-1 products warn about pancreatitis, gallbladder disease, renal injury from dehydration, and interactions with insulin secretagogues. Bring questions—not internet answers—about:
- Combining GLP-1 with insulin
- Combining with oral contraceptives (GI absorption nuances in labeling)
- Surgery planning and NPO instructions
- Retatrutide or investigational names seen online
Access and product authenticity belong in clinician GLP-1 access conversations.
Mitochondrial and GH-Axis Peptides
Forum stacks often mix MOTS-c, SS-31, tesamorelin, ipamorelin, and GLP-1 drugs. Human interaction data for these combinations in non-research settings is limited. Treat them as high uncertainty and prioritize prescriber-led plans. Educational background: mitochondrial peptide primer.
How to Hand This to a Provider
Export PeptIQ summaries or print a one-page table:
| Compound | Dose/Route | Start | Source | Indication (per clinician) |
|---|
Highlight changes in the last 14 days in bold. Clinicians scan deltas first.
Sources
Frequently Asked Questions
Q: Should I list supplements I took once last month?
A: List recurring supplements and anything taken during the symptom window you are discussing.
Q: Will my doctor judge me for research peptides?
A: Clinicians need honesty to manage risk. Documentation improves care; secrecy worsens it.
Q: Can PeptIQ detect interactions automatically?
A: No. It organizes data you share with licensed professionals.
Q: How often should I update the checklist?
A: After any new vial, prescription change, or titration—at minimum before each visit.
Q: Is stacking two GLP-1 drugs ever appropriate?
A: Not without specialist oversight; generally avoid combining agonists in the same class.
Q: What if I do not know the concentration of a mixed vial?
A: Stop guessing doses; remeasure with the reconstitution calculator and relabel, or discard per clinician advice.
High-Risk Combination Themes to Flag Early
Bring these to clinical review even if you hope the answer is "fine":
- Multiple glucose-lowering pathways (GLP-1 plus insulin secretagogues)
- QT-prolonging medicines plus stimulant fat burners
- Immunosuppressants plus experimental peptides with immune marketing claims
- Anticoagulants plus frequent injection site trauma without rotation
- Thyroid hormones plus GH-axis secretagogues affecting glucose
PeptIQ tags can mark high-alert combos you want reviewed every visit.
Supplements that mimic medicines
Berberine, cinnamon extracts, and "GLP-1 booster" capsules are not inert. List them explicitly. Clinicians cannot guess what is in proprietary blends—photograph labels.
When stopping a stack item, log stop date and reason (side effect, cost, clinician order). Attribution improves when removals are dated.
Emergency and Urgent Care Cards
For urgent visits, export a minimal stack list: name, dose, route, last dose time. Emergency clinicians may not know peptide trade names. Include prescription numbers and pharmacy phone for verified medicines.
Research peptides should be described honestly as non-prescription research products if that is what they are—mislabeling them as vitamins obstructs care.
Update the checklist after COA or cold-chain events that caused lot replacements—new lots are stack changes too.
PeptIQ Export Habits for Care-Team Conversations
Structured tracking earns its keep when you leave the house. Before a clinic or telehealth visit, export or screenshot four views: active vials and lots, injection site map summary, symptom timeline for the last 30 days, and concurrent medicine list pulled from your stack notes. Clinicians rarely need every historical row; they need deltas and clarity.
When you mention a side effect, tie it to lot, site, and calendar context (travel, illness, titration). That triad prevents the common failure mode where patients remember mood but forget a fridge outage or pharmacy switch. If you use web tools, link calculator outputs and shelf-life assumptions in the same vial record so nobody confuses educational estimates with pharmacist beyond-use dates.
Privacy matters: redact account identifiers if you share images in patient portals. Keep peptide names spelled exactly as labels read, including salt forms and brand names for GLP-1 devices. PeptIQ is an educational organizer—not a medical record system of record—so confirm what your clinic accepts before uploading.
Finally, schedule a quarterly data hygiene pass: retire finished vials, archive one-off experiments, and update stack checklists. Clean data makes every article in this series more actionable, from COA review to half-life literacy.
Evidence Literacy Reminder
Online peptide culture rewards certainty. Medical practice rewards uncertainty management. When a post claims "everyone feels X on day three," ask what population, route, and product were studied—if any. Prefer FDA accessdata labeling for approved medicines, USP references for compounding quality concepts, CDC materials for injection and storage discipline, and PubMed-indexed publications for research peptides.
PeptIQ does not validate suppliers or replace clinicians. It helps honest learners keep questions organized: What lot did I use? What changed last week? What professional told me to stop? Those questions stay relevant whether you study mitochondrial peptides, GLP-1 mechanisms, or reconstitution math.
If this guide linked to calculators or tools, use them to document assumptions, not to bypass supervision. Download the mobile app when you want injection reminders and notes in the same timeline as your research reading—education and execution stay linked.
This article is educational content from PeptIQ. It is not medical advice. Talk with a licensed clinician before starting, stopping, or changing any peptide, medication, or injection practice.
